Fulcrum Therapeutics
FULC
FULC
38 hedge funds and large institutions have $262M invested in Fulcrum Therapeutics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
-1
Holders Change %
-2.56%
% of All Funds
0.75%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
3
Increased
15
Reduced
11
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CC
Casdin Capital
New York
|
+$6.57M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.39M |
| 3 |
BlackRock
New York
|
+$1.93M |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$1.06M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$962K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$3.68M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$3.38M |
| 3 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$3.12M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.24M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$1.02M |
